Metraipolis › archive › dc_ce82efe08b44

FLT3: A 35-Year Voyage from Discovery to the Next Generation of Targeted Therapy in AML — Europe PMC PMID:41228209

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41228209
DOI: 10.3390/cancers17213415
License (as archived): solo-consultazione
Archived: 2026-11-09T02:44:43.309Z
SHA-256 of the archived text: 163221ac1b7ee97e9d42d4cd0fed0ba2d5ccd251579ddb2a67b9621deda95220
Stable URL of this page: https://metraipolis.com/documento/dc_ce82efe08b44

How to cite

FLT3: A 35-Year Voyage from Discovery to the Next Generation of Targeted Therapy in AML — Europe PMC PMID:41228209 — Europe PMC (en), https://europepmc.org/article/MED/41228209 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce82efe08b44 (Metraipolis archive dc_ce82efe08b44, sha256 163221ac1b7ee97e9d42d4cd0fed0ba2d5ccd251579ddb2a67b9621deda95220)

BibTeX

@misc{dcce82efe08b44,
  title = {FLT3: A 35-Year Voyage from Discovery to the Next Generation of Targeted Therapy in AML — Europe PMC PMID:41228209},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41228209},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce82efe08b44; sha256 163221ac1b7ee97e9d42d4cd0fed0ba2d5ccd251579ddb2a67b9621deda95220},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41228209. Agents can read the archived copy with the MCP tool read_document.